This White Paper Showcase will describe the current applications of actigraphy in clinical trials, important considerations when including actigraphy in the protocol, regulatory aspects, and current research that can increase the value of actigraphy in the near future.

Brought to you by Philips Respironics.

**Attendee badges scanned for this White Paper Showcase will be shared with the Company hosting this offering. If you prefer not to have your badge scanned, please inform the DIA staff member.

Learning Objectives:
Describe how and when actigraphy can improve clinical drug studies
Explain the importance of logistics and data analysis/management for getting successful results
Identify the likelihood of increased value of actigraphy based on advances in technology, regulatory environment, and better understanding of the data.